Neurodegeneration
Does T2DM impair glymphatic flow on DTI-ALPS?
Open access · cc by · source: Europe PMC
In 30 adults, longer T2DM history tracked with lower ALPS-index values, suggesting reduced perivascular water diffusivity.
Study at a glance
- Design
- Case-control — DTI-ALPS comparison of T2DM duration groups vs controls
- N
- N=30 · 10 ≥10 y T2DM, 10 <10 y T2DM, 10 controls
- Population
- Adults with type 2 diabetes and age-matched controls imaged at lateral ventricle body plane
- Outcome
- Directional diffusivities and ALPS-index as glymphatic activity markers
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
ALPS-index and perivascular-aligned diffusivity differed by T2DM history (key contrasts P < 0.001); authors interpret lower ALPS as glymphatic impairment.
Methodology
Calculated directional diffusivities and ALPS-index from DTI at the lateral ventricle body in ≥10 y T2DM, <10 y T2DM, and controls (n=10 each).
Limitations
Causal proof that diabetes damages glymphatics, or that ALPS equals true CSF clearance; sample is small and cross-sectional.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Not yet placed on a claim. This paper has study layers, but no concept page yet cites it as support, challenge, or qualifier.
Related papers in this topic
Same topic cluster — not a recommendation engine.
- How tau buildup shapes brain networks in dementia
- How does brain structure change in early Parkinson's disease?
- How does brain inflammation affect connectivity and thinking in AD?
- Can a new PET imaging tracer distinguish different tau diseases?
- Does brain region loss predict memory decline in Parkinson's?